+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Impact of Diabetes Mellitus on Cardiac Sympathetic Innervation in Patients With Heart Failure A 123I meta-iodobenzylguanidine 123I MIBG scintigraphic study



Impact of Diabetes Mellitus on Cardiac Sympathetic Innervation in Patients With Heart Failure A 123I meta-iodobenzylguanidine 123I MIBG scintigraphic study







Impaired parasympathetic and sympathetic nervous system activity have been demonstrated in patients with diabetes mellitus (DM) and correlated with worse prognosis. Few data are available on the effect of DM on cardiac neuropathy in heart failure (HF). The aim of the current study was to assess cardiac sympathetic activity in HF patients with and without DM. Patients with severe HF (n = 75), with (n = 37) and without DM (n = 38), and 14 diabetic patients with normal cardiac function underwent 123I meta-iodobenzylguanidine scintigraphy from which early and late heart-to-mediastinum (H/M) ratios were calculated. Clinical, echocardiographic, and biochemical data were measured. DM compared with non-DM patients showed significantly lower early (1.65 ± 0.21 vs. 1.75 ± 0.21; P < 0.05) and late H/M ratios (1.46 ± 0.22 vs. 1.58 ± 0.24; P < 0.03). Early and late H/M were significantly higher in DM patients without HF (2.22 ± 0.35 and 1.99 ± 0.24, respectively) than HF patients with (P < 0.0001) and without (P < 0.0001) DM. In HF patients, an inverse correlation between early or late H/M ratio and hemoglobin A1c (HbA1c) (Pearson = –0.473, P = 0.001; Pearson = –0.382, P = 0.001, respectively) was observed. In DM, in multivariate analysis, HbA1c and ejection fraction remained significant predictors of early H/M; HbA1c remained the only significant predictor of late H/M. No correlation between early or late H/M and HbA1c was found in non-DM patients. Diabetic patients with HF show lower cardiac sympathetic activity than HF patients not having DM or than DM patients with a similar degree of autonomic dysfunction not having HF. HbA1c correlated with the degree of reduction in cardiac sympathetic activity.

Accession: 036942019

Download citation: RISBibTeXText


Related references

Impact of diabetes on cardiac sympathetic innervation in patients with heart failure: a 123I meta-iodobenzylguanidine (123I MIBG) scintigraphic study. Diabetes Care 36(8): 2395-2401, 2013

Impact of Diabetes Mellitus on Cardiac Sympathetic Innervation in Patients With Heart Failure A 123I meta-iodobenzylguanidine 123IMIBG scintigraphic study. 2013

Sympathetic cardiac function in early sepsis: Noninvasive evaluation with [ 123 I]-meta-iodobenzylguanidine ( 123 I-MIBG) in vivo SPECT imaging. Journal of Nuclear Cardiology 25(2): 483-491, 2018

Assessment of sympathetic innervation of the heart in diabetes mellitus using 123I-MIBG. Diabetes Nutrition and Metabolism 13(6): 350-355, 2000

Quantitative 123I-MIBG SPECT/CT assessment of cardiac sympathetic innervation--a new diagnostic tool for heart failure. International Journal of Cardiology 168(2): 1556-1558, 2013

A radiological analysis of heart sympathetic functions with meta-[123I]iodobenzylguanidine in neurological patients with autonomic failure. Journal of the Autonomic Nervous System 49(1): 81-84, 1994

123I-MIBG scintigraphic assessment of sympathetic innervation in hypertrophic cardiomyopathy patients with and without severe tachyarrhythmias. European Heart Journal 23(Abstract Suppl.): 120, 2002

Functional derangement and cardiac innervation in the apical ballooning syndrome: a 123I-meta-iodobenzylguanidine scintigraphic and dobutamine stress echocardiographic study. Journal of Cardiovascular Medicine 8(3): 205-209, 2007

Myocardial uptake of meta-[123I]-iodobenzylguanidine [( 123I]-MIBG) in patients with myocardial infarct. European Journal of Nuclear Medicine 15(9): 624-628, 1989

Scintigraphic assessment of sympathetic myocardial innervation by 123I-MIBG imaging in patients with nonischemic ventricular tachycardia or fibrillation. Circulation 92(8 Suppl. ): I548, 1995

Evaluation of cardiac sympathetic innervation with 123I-metaiodobenzylguanidine in patients with diabetes mellitus. Revista Espanola de Cardiologia 51(Suppl. 1): 60-66, 1998

Relationship between quantitative cardiac neuronal imaging with ¹²³I-meta-iodobenzylguanidine and hospitalization in patients with heart failure. European Journal of Nuclear Medicine and Molecular Imaging 41(9): 1666-1672, 2014

Alterations of left ventricular deformation and cardiac sympathetic derangement in patients with systolic heart failure: a 3D speckle tracking echocardiography and cardiac ¹²³I-MIBG study. European Journal of Nuclear Medicine and Molecular Imaging 42(10): 1601-1611, 2015

Validation of 2-year 123I-meta-iodobenzylguanidine-based cardiac mortality risk model in chronic heart failure. European Heart Journal Cardiovascular Imaging 19(7): 749-756, 2018

A scintigraphical qualitative analysis of peripheral vascular sympathetic function with meta-[123I]iodobenzylguanidine in neurological patients with autonomic failure. Journal of the Autonomic Nervous System 53(2-3): 230-234, 1995